NIH-funded research R01 grant

How a Mediterranean-style diet changes blood and urine markers tied to heart disease

Official title: Mediterranean diet, Metabolites, and Cardiovascular Disease

Funded at Harvard University D/b/a Harvard School of Public Health · NIH-11416109 · Data updated 2026-11-12

This project looks at whether chemicals in urine and blood that change with a Mediterranean-style diet relate to future heart attack, stroke, or heart failure risk in adults.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard University D/b/a Harvard School of Public Health
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 15, 2013
Project endFebruary 28, 2027
Funding year2025
Award (this year)$70,526
NIH project number3R01HL118264-12S2
Project IDNIH-11416109 on NIH RePORTER

Who could benefit from this research

Could help

Findings are most relevant to older adults or people with heart disease risk factors similar to those who enrolled in the PREDIMED trial (people at high cardiovascular risk).

Less likely to help

Young, healthy people with low cardiovascular risk may not directly benefit because the work focuses on an older, higher-risk population.

What this research studies

Researchers are using stored blood and urine samples from people who took part in the PREDIMED trial to measure many small molecules (metabolites). They compare a randomly selected subcohort with participants who later had heart attacks, strokes, heart failure, or cardiovascular death to find metabolites linked to the diet and disease. The team will study changes from baseline to one year after the dietary intervention to identify metabolite patterns tied to the Mediterranean diet and its main foods. Urine and plasma metabolomics are combined with statistical models to build biomarkers that could help tailor diet advice in the future.

Why it matters

Potential benefit: If successful, this work could produce simple urine or blood biomarker panels that reflect adherence to a heart-healthy Mediterranean diet and help predict future cardiovascular risk.

How similar studies have gone: The original PREDIMED trial showed the Mediterranean diet reduces cardiovascular events, and emerging metabolomics work has begun linking diet patterns to biomarkers, though the combined urine-plus-plasma multi-metabolite approach is relatively new.

Where this research is happening

  • Harvard University D/b/a Harvard School of Public Health
    Boston, United States
    Active

Researchers

  • Principal investigator: Hu, Frank B — Harvard University D/b/a Harvard School of Public Health
  • Study coordinator: Hu, Frank B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.